Kendall DM et al (2009): Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use
Weight-based dosing considerations The standard semaglutide protocol does not adjust for body weight
In 1981, for example, a paper published in the International Journal of Clinical Pharmacology, Therapy, and Toxicology described a trial with six volunteers who experienced immediate sleep pressure after intravenous DSIP infusion, as well as increased sleep time, decreased sleep onset, and better sleep efficiency without any sedative effects.13 Three years later, two other human trials across ten test subjects with insomnia found that DSIP administration yielded statistically significant improvements in several key sleep measures fewer sleep arousals, greater sleep efficiency, and increased REM, spindle, and slow-wave sleep.14 The above studies had shortcomings, namely their very small sample sizes, but the sleep-improving effects in cases of insomnia point to DSIPs potential to live up to its name
doi: 10.1371/journal.pone.0004962 77 DuarteAISjgrenMSantosMSOliveiraCRMoreiraPIBjrkqvistM
Combination with Other Peptides : CJC-1295 is often used in combination with other peptides like Ipamorelin or Sermorelin , which also stimulate GH release